Stockreport

Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement

Valneva SE - American Depositary Shares  (VALN) 
PDF Saint-Herblain (France), Pune, (India), December 31, 2025 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, and Serum Institute of India (SII), a C [Read more]